Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment

Two open‐label studies assessed the safety, tolerability, and pharmacokinetics of Oxbryta (voxelotor) in subjects with hepatic or renal impairment. Eight subjects with severe renal impairment (estimated glomerular filtration rate <30 mL/min/1.73 m(2)) and 8 healthy age‐, sex‐, and body mass index...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Pharmacol
Main Authors: Preston, Richard A., Marbury, Thomas, Balaratnam, Ganesh, Green, Michelle, Dixon, Sandy, Lehrer‐Graiwer, Josh, Washington, Carla
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Editor's Choice: Special Populations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984382/
https://ncbi.nlm.nih.gov/pubmed/33084052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1757
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker